Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.64 |
| ▸ | ADCY1 | Q08828 | 15/20 | 0.56 |
| ▸ | ADCY8 | P40145 | 12/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23249621 | 0.89 | SLC2A1 (0.63) | SLC2A1ADCY1ADCY8HTR2B | |
| SCHEMBL23259374 | 0.88 | SLC2A1 (0.67) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL20673074 | 0.88 | ADCY1 (0.72) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL23249699 | 0.86 | SLC2A1 (0.67) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL20673021 | 0.85 | SLC2A1 (0.81) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL20673019 | 0.85 | SLC2A1 (0.65) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL23249330 | 0.85 | SLC2A1 (0.47) | SLC2A1ADCY1ADCY8HTR2BMEN1 | |
| SCHEMBL23249727 | 0.84 | SLC2A1 (0.64) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL23249753 | 0.83 | SLC2A1 (0.63) | SLC2A1ADCY1ADCY8HTR2BNPSR1 | |
| SCHEMBL23259437 | 0.83 | SLC2A1 (0.54) | SLC2A1ADCY1ADCY8HTR2BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240139190-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-05-02 | — | — | US | disclosed |
| WO-2021077102-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021077102-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139190-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | TUBB, TUBB1, TUBA1C | SLC2A1 4433/4885ADCY1 4578/4885ADCY8 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.